KADOWAKI Hiromu    Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine    Position   Assistant Professor
Language	English
Title	Successful withdrawal of implantable left ventricular assist device in a case with major cerebrovascular complication
Conference	The 21st Annual Scientific Meeting of the Japanese Heart Failure Society
Promoters	Japanese Heart Failure Society
Conference Type	Nationwide Conferences
Presentation Type	Poster notice
Lecture Type	General
Publisher and common publisher	◎KADOWAKI Hiromu, TSUKAMOTO Kei, KIKUCHI Noriko, HATTORI Hidetoshi, SERIZAWA Naoki, NUNODA Shinichi, HAGIWARA Nobuhisa, TATEISHI Monori, SAITO Satoshi, YAMAZAKI Kenji
Date	2017/10/12
Venue (city and name of the country)	Akita, JAPAN
Society abstract	Journal of Cardiac Failure 23(10),S73 2017
Summary	A 55-year-old man with dilated cardiomyopathy (DCM) showed refractory heart failure despite of optical medical therapy and was admitted to our hospital in July 10, 2012. He was registered as a candidate for heart transplantation in Japan, and underwent implantation of a left ventricular assist device (LVAD) (EVAHEART). During the following period, however, he suffered brain hemorrhagic infarction several times and his cognitive function drastically declined, and he had to be moved from Status 1 to 3. Because his recovery on his cardiac function was simultaneously observed (LVEF; 15 to 45%), we tried to wean from LVAD. During this trial, we assessed change of his hemodynamics through by reducing rotation speed of the centrifugal pump and confirmed that no significant hemodynamic worsening was occurred. We successfully removed his LVAD at 1722 days after LVAD implantation, and he has been stable. Destination therapy by LVAD implantation is not approved in Japan and we report successful withdrawal of LVAD in a case with major cerebrovascular complication and showing late recovery of cardiac function.